Search for: "Watson v. Delaware"
Results 41 - 60
of 79
Sorted by Relevance
|
Sort by Date
3 Apr 2009, 4:50 am
(IPKat) US: Third follow-on biologics bill, Promoting Innovation and Access to Life-Saving Medicine Act in 111th Congress; draws industry ire (Patent Docs) (Law360) US: CAFC: Anticipation of genus by prior art species in long list: In re Gleave (Hal Wegner) (Patent Docs) US: Life Technologies, General Electric settle patent suit over DNA amplification kits (Law360) Products Concerta (Methylphenidate) – US: Delaware court rules Watson does not infringe patent… [read post]
6 Jul 2011, 2:21 am
Pharmacia & Upjohn in liquidazione and Pfizer Italia s.r.l (Kluwer Patent Blog) US: IPO releases list of top 300 patent holders for 2010 (Patent Docs) US: Supreme Court to hear more patent cases in October 2011 term: Mayo v Prometheus; Kappos v Hyatt; Caraco v Novo Nordisk (Inventive Step) US: In pleading inequitable conduct, inventor’s citation to withheld reference does not establish knowledge of reference sufficient to satisfy FRCP 9(b): Fred Hutchinson Cancer… [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
6 Feb 2014, 3:09 pm
In Silverberg v. [read post]
3 Nov 2010, 1:21 am
Pharmachemie (EPLAW) US: Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US: DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) US: Briefing update: AMP v USPTO (Patent Docs) US: BIO and AUTM file amicus brief in Myriad case (PatentlyBIOtech) US: Myriad files appeal brief in AMP v USPTO (Patent… [read post]
6 Sep 2019, 5:39 am
Serio, Gibson, Dunn & Crutcher LLP, on Tuesday, September 3, 2019 Tags: Appraisal rights, Delaware cases, Erica John Fund v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
28 Apr 2010, 9:26 pm
ALZA Corp. v. [read post]
28 Dec 2021, 9:42 am
Buyer v. [read post]
20 Mar 2020, 6:17 am
Posted by Ruth V. [read post]
19 Jan 2018, 6:30 am
National Australia, Omnicare, Salman, SEC, SEC enforcement, Section 10(b), Securities Act, Statute of limitations, Supreme Court, U.S. federal courts, Whistleblowers Delaware’s Prudent Approach to the Cleansing Effect of Stockholder Approval Posted by William Savitt, Wachtell, Lipton, Rosen & Katz, on Tuesday, January 16, 2018 Tags: Controlling shareholders, Corwin, Delaware… [read post]
19 May 2008, 8:55 am
Supreme Court, May 12, 2008 Gonzales v. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Aplenzin (Bupropion) - US: District Court Delaware: Patent infringement complaint filed following a Paragraph IV Certification: Biovail Laboratories International SRL v. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) – US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP… [read post]
21 Feb 2020, 6:13 am
Silk, and Sabastian V. [read post]
22 Jul 2016, 6:10 am
Schreiner, Monteverde & Associates PC, on Wednesday, July 20, 2016 Tags: Boards of Directors, Business judgment rule, Delaware cases, Delaware law, Disclosure, Discovery, Duty of care,Information asymmetries, Merger litigation, Mergers & acquisitions, Shareholder rights, Shareholder voting Yet Another Congressional Proposed Corporate Reform: Proxy Advisory Firms in the Crosshairs Posted by Ed Batts, Orrick, Herrington & Sutcliffe LLP, on Wednesday, July 20, 2016 … [read post]
